A new French drug to treat hepatitis C virus in its six forms

A new French drug to treat hepatitis C virus in its six forms


For the first time, the French pharmacies and hospitals have seen the latest drug to treat 6 forms of hepatitis C, which is called the "Maveret", which was produced and marketed by the American labs "August", which is sold at 28 thousand euros, is given to patients who do not have fibrosis in the liver, and continue treatment for 8 weeks.

Pierre Claude Fumoulou, head of the branch of the "Fab" in France, said that this drug is dispensed by a medical prescription for a specialist doctor. Hepatitis disease is a silent disease, affecting more than 75 thousand French citizens, the vast majority of whom are unaware of the disease. It has no symptoms or introductions.

Fumolo has advised a specialist to identify the disease. His treatment is high in price, such as the drug Suvaldine, which costs 40,000 euros and other drugs such as Harvey.
For the first time, the French pharmacies and hospitals have seen the latest drug to treat 6 forms of hepatitis C, which is called the "Maveret", which was produced and marketed by the American labs "August", which is sold at 28 thousand euros, is given to patients who do not have fibrosis in the liver, and continue treatment for 8 weeks.

Pierre Claude Fumoulou, head of the branch of the "Fab" in France, said that this drug is dispensed by a medical prescription for a specialist doctor. Hepatitis disease is a silent disease, affecting more than 75 thousand French citizens, the vast majority of whom are unaware of the disease. It has no symptoms or introductions.

Fumolo has advised a specialist to identify the disease. His treatment is high in price, such as the drug Suvaldine, which costs 40,000 euros and other drugs such as Harvey.